Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility The inspection, conducted between December 9 and December 17, 2024, resulted in two procedural observations from the US FDA. Manoj Reddy Sama / Wednesday, December 18, 2024 0 170 Article rating: 4.3 The facility in question, Unit-V, is an active pharmaceutical ingredient (API) manufacturing site operated by Apitoria Pharma Private Ltd, a wholly owned subsidiary of Aurobindo Pharma, located in Pashamylaram Village, Telangana. Read more
Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches! Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches! With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence Pushkar Shinde / Monday, November 11, 2024 0 170 Article rating: 5.0 With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence Read more
This pharma company's shares surged to a new 52-week high after receiving final approval from the USFDA. This pharma company's shares surged to a new 52-week high after receiving final approval from the USFDA. The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger with over 260 per cent returns in the last two years. Ashwin Urkude / Friday, August 9, 2024 0 307 Article rating: 3.7 The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger with over 260 per cent returns in the last two years. Read more
This pharma company stock went 8 per cent high, do you own it? This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore. Kiran Shroff / Thursday, November 10, 2022 0 1378 Article rating: 5.0 This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore. Read more
Heavy buying seen in these small-caps that hit fresh 52 week high on August 18! Heavy buying seen in these small-caps that hit fresh 52 week high on August 18! On BSE, 265 stocks have hit their upper circuits whereas 131 stocks touched their lower circuits. Sayali Kotwal / Thursday, August 18, 2022 0 5800 Article rating: 4.2 At 2.30 pm on Thursday, the markets were seen recovering from the day’s low as Asia- Pacific markets tumbled following the overnight cooling off of the most recent Wall Street rise. Read more
Lupin hit the ball out of the park! Is the tide turning in favour of the stock after this big announcement? Lupin hit the ball out of the park! Is the tide turning in favour of the stock after this big announcement? Karan Dsij / Tuesday, December 14, 2021 0 715 Article rating: 3.7 Another interesting point is that it’s not very usual these days to see pharma stock jumping 8-9 per cent but on Tuesday, Lupin broke this jinx as it soared nearly 9 per cent. Certainly, this might have brought a million-dollar smile to the faces of Lupin investors. Read more